ASAPF (Aurora Spine) Growth Rank: 2 (As of Jul. 08, 2026) — 100% Above Median


ASAPF Aurora Spine Corp ASAPF
38 GF Score
Price $0.17
GF Value $0.23
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Aurora Spine Growth Rank?

Aurora Spine ASAPF 38 Growth Rank is 2 as of Jul. 08, 2026, which is 100% above its 10-year median of 1.00. GuruFocus rates ASAPF with a GF Score™ of 38/100 and a GF Value™ of $0.23 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Aurora Spine has the Growth Rank of 2.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

ASAPF vs ABT, SYK, MDT: Growth Rank Comparison

For the Medical Devices subindustry, Aurora Spine's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Spine Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's Growth Rank distribution charts can be found below:

* The bar in red indicates where Aurora Spine's Growth Rank falls into.


ASAPF
38GF Score
Aurora Spine Corp ASAPF
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 2 mean?
Aurora Spine (ASAPF) has a Growth Rank of 2 as of Jul. 08, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Aurora Spine and its competitors. This is 100% above median its historical median of 1.00. Over the past decade, Aurora Spine's Growth Rank has ranged from 1.00 to 7.00.
Is Aurora Spine's Growth Rank too high?
Aurora Spine's current Growth Rank of 2 is 100% above median its 10-year median of 1.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. Overall, Aurora Spine has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's Growth Rank compare to ABT and SYK?
Aurora Spine's Growth Rank of 2 can be compared against companies in the Medical Devices & Instruments industry. Historically, Aurora Spine's own Growth Rank has ranged from 1.00 to 7.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Aurora Spine and its competitors. Aurora Spine's current Growth Rank is 2, which is 100% above median its own 10-year median of 1.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.23, compared to a current price of $0.17 — trading 28.3% below its estimated fair value. The current Growth Rank is 2, which is 100% above median its 10-year median of 1.00. Aurora Spine's overall GF Score™ is 38/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current Growth Rank is 2 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.17 is trading 28.3% below its estimated GF Value™ of $0.23. GuruFocus considers Aurora Spine to be Modestly Undervalued.

Key valuation signals for ASAPF:

  • Growth Rank: 2 (100% above median its 10-year median of 1.00)
  • GF Value™: $0.23 vs. price of $0.17 (28.3% below fair value)
  • GF Score™: 38/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
38GF Score

Get the complete analysis for ASAPF

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.23
GF Value